tykhr
sign in
free sign up
Rapport Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
RAPP
354 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
26.21
52 week high
31.47
high
27.94
52 week low
0.00
low
26.06
growth
25.53 %
previous Close
26.11
P/E ratio
market cap
584 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-26.73 M
-11.09 %
eps
0.00 %
-10.29 %
eps surprise
2.60 %
net profit margin
-2673200000.00 %
0.00 %
operating incoming
-29.50 M
-8.81 %
net change in cash
-2.54 M
-417.52 %
cash on hand
55.07 M
-4.40 %
cost of revenue
252 K
0.00 %
top